当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析

金城医药

(300233)

  

流通市值:63.41亿  总市值:65.49亿
流通股本:3.72亿   总股本:3.84亿

金城医药(300233)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.34亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益371740.86万元,未分配利润78468.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产514105.29万元,负债142364.42万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,932,025,566.291,360,240,655.35721,919,205.163,373,387,400.67
营业总成本1,891,362,105.71,309,982,354.22682,091,200.853,103,164,108.88
其他经营收益
营业利润52,885,072.1262,117,305.6750,092,786.77267,138,172.88
利润总额50,577,835.1159,784,979.6549,799,982.84268,448,023.16
净利润33,598,077.7244,966,077.7536,298,903.66207,735,344.13
每股收益
其他综合收益-33,584.91-2,100,000-23,268,580.25
综合收益总额33,564,492.8142,866,077.7536,298,903.66231,003,924.38
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,894,736,087.252,005,084,614.412,184,257,009.162,258,285,131.73
非流动资产:
非流动资产合计3,246,316,788.93,278,243,502.333,287,127,224.513,346,705,609.98
资产总计5,141,052,876.155,283,328,116.745,471,384,233.675,604,990,741.71
流动负债:
流动负债合计1,084,641,538.451,093,345,748.841,122,888,801.631,230,974,936.04
非流动负债:
非流动负债合计339,002,696.18425,709,762.35535,067,733.94541,861,651.66
负债合计1,423,644,234.631,519,055,511.191,657,956,535.571,772,836,587.7
所有者权益(或股东权益):
归属于母公司股东权益合计3,650,215,453.433,697,517,562.343,747,011,365.753,766,981,964.99
股东权益合计3,717,408,641.523,764,272,605.553,813,427,698.13,832,154,154.01
负债和股东权益合计5,141,052,876.155,283,328,116.745,471,384,233.675,604,990,741.71
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,771,631,144.061,223,105,757.57598,515,054.412,983,715,110.85
经营活动现金流出小计1,587,448,882.491,118,737,846607,080,446.362,687,129,386.68
经营活动产生的现金流量净额184,182,261.57104,367,911.57-8,565,391.95296,585,724.17
投资活动产生的现金流量:
投资活动现金流入小计749,919,604.9498,447,840.87288,038,948.22412,443,966.46
投资活动现金流出小计887,302,639.62525,469,377.05297,561,108.78496,759,683.16
投资活动产生的现金流量净额-137,383,034.72-27,021,536.18-9,522,160.56-84,315,716.7
筹资活动产生的现金流量:
筹资活动现金流入小计137,975,000126,975,000108,000,000245,490,000
筹资活动现金流出小计432,966,504.58390,516,230.81173,461,298.33489,260,905.66
筹资活动产生的现金流量净额-294,991,504.58-263,541,230.81-65,461,298.33-243,770,905.66
汇率变动对现金及现金等价物的影响1,973,205.381,867,868.361,463,5855,963,880.28
现金及现金等价物净增加额-246,219,072.35-184,326,987.06-82,085,265.84-25,537,017.91
期末现金及现金等价物余额632,265,038.05694,157,123.34796,398,844.56878,484,110.4
补充资料:
现金及现金等价物的净增加额--184,326,987.06--25,537,017.91
TOP↑